Next Article in Journal
Proteomic Analysis Identifies Distinct Protein Patterns for High Ovulation in FecB Mutant Small Tail Han Sheep Granulosa Cells
Next Article in Special Issue
Effects of Bacillus subtilis on Growth Performance, Metabolic Profile, and Health Status in Dairy Calves
Previous Article in Journal
How Useful Are Existing Protocols in the Quick Assessment of the Welfare of Semi-Feral Horses? Pilot Study on Konik Polski Horses Living in the Forest Sanctuary
Previous Article in Special Issue
Heat Inactivation of Methicillin-Resistant Staphylococcus aureus Strains from German Dairy farms in Colostrum and Raw Milk
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Animals
Volume 14
Issue 1
10.3390/ani14010010
animals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effect of Prepartum Maternal Supplementation with Diphenyl Diselenide on Biochemical, Immunological, and Oxidative Parameters of the Offspring

by
Cláudia Medeiros Rodrigues
1,*,
Eliana Burtet Parmeggiani
1,
Karoline Wagner Leal
1,
Marla Schneider
2,
Silvana Giacomini Collet
3,
Francielli Weber Santos Cibin
4,
Viviani Gomes
5,
Maiara Garcia Blagitz
6,
João Batista Teixeira da Rocha
7 and
Marta Lizandra do Rêgo Leal
1,*
1
Department of Large Animal Clinic, Federal University of Santa Maria, Santa Maria 97105-900, RS, Brazil
2
Veterinary Medicine Course, Central Education Unit Faem Faculty, Chapecó 89812-214, SC, Brazil
3
Veterinary Medicine Course, University of West Santa Catarina, Xanxerê 89820-000, SC, Brazil
4
Oxidative Stress Laboratory, Federal University of Pampa, Uruguaiana 97501-970, RS, Brazil
5
Department of Clinical Medicine, Faculty of Veterinary Medicine and Zootechnics, University of São Paulo, São Paulo 05508-270, SP, Brazil
6
Veterinary Medicine Course, Federal University of the Southern Border, Realeza 85770-000, PR, Brazil
7
Department of Biochemical and Molecular Biology, Federal University of Santa Maria, Santa Maria 97105-900, RS, Brazil
*
Authors to whom correspondence should be addressed.
Animals 2024, 14(1), 10; https://doi.org/10.3390/ani14010010
Submission received: 3 November 2023 / Revised: 6 December 2023 / Accepted: 15 December 2023 / Published: 19 December 2023
(This article belongs to the Special Issue Advances in Calf Health and Performance)
Browse Figures
Review Reports Versions Notes

Abstract

:

Simple Summary

The rearing of calves is a challenging phase in the production of dairy cattle. These animals face challenges from birth, as they require ingestion of colostral immunoglobulins for transfer of passive immunity, given that their immune systems are still immature. If there is a failure in the transfer of passive immunity, they become vulnerable to disease. This vulnerability, combined with stressors such as weaning, can predispose them to cellular oxidative stress. Similarly, to the immune system, the antioxidant defense system is also in the developmental stage, therefore, providing antioxidant substances during this phase could be a valuable option. Considering this, our team proposed to assess the impact of prepartum maternal selenium supplementation on the offspring, given its established benefits and its transfer through the placenta, colostrum, and milk. Diphenyl diselenide, an organic analog, was selected because of its anti-inflammatory and antioxidant properties. It can be administered safely subcutaneously, ensuring the correct dosage and facilitating its use at strategic times without any risk of toxicity. Maternal supplementation with diphenyl diselenide has been found to significantly increase passive immunity transfer rates in calves, as well as help establish and improve humoral immunity. This provides new insight into the immunomodulatory capabilities of this molecule.

Abstract

This study aimed to assess the impact of prepartum maternal diphenyl diselenide (PhSe)2 supplementation on the development, biochemical, immune, and antioxidant parameters of calves. Eighteen Holstein breed calves were used, born to females who were or were not subjected to supplementation, at 42, 28, and 14 days prior to calving. The (PhSe)2 group (DDG) was administered 3 μmol/kg of (PhSe)2 in 4 mL of dimethyl sulfoxide (DMSO), while the DMSO and NaCl groups were administered 4 mL of DMSO and 0.9% NaCl, subcutaneously. The calves were evaluated based on their weight, withers height, body condition score 24 h post-birth (0), as well on days 14, 28, 42, 56, 70. Blood samples were also taken to determine serum variables. Calves on the DDG showed higher average levels of total protein, albumin, and globulins on day 0, and the immunoglobulin G level was significantly higher than the other groups on days 0, 14, 56, 70. Maternal supplementation showed immunomodulatory effect on calves, evidenced by the exceptional rates of passive immunity transfer, as well as the enhancement of humoral immunity. Our research offers fresh insights into the immunomodulatory potential of (PhSe)2, making it a viable alternative in facing this challenging phase, rearing dairy calves.

1. Introduction

The period extending from the neonatal phase to the weaning of calves is considered a critical stage in dairy cattle production, given the numerous challenges encountered during this timeframe. First, these animals depend on the proper passive transfer of maternal colostral immunoglobulins for their protection since their immune system continues to develop even after birth. If the colostration process is not executed correctly, there will be a failure in the transfer of passive immunity [1]. This condition increases the vulnerability of animals to diseases that typically arise during this period, such as diarrhea, pneumonia, and omphalopathy [2]. These diseases are strongly associated with calf mortality as well as weight loss and/or reduced weight gain in the surviving animals [3].
The intrauterine conditions to which the fetus is exposed during pregnancy significantly impact the immune function, health, and even milk production [4]. These factors have been related to the occurrence of metabolic and oxidative stress (OS), triggered by mother’s exposure to heat stress, and restricted or excessive energy intake [5]; in humans there are already reports of cases of the restriction of intrauterine growth triggered by OS [6]. Furthermore, shortly after birth, calves are exposed for the first time to an environment rich in O2. As soon as the breathing process begins, there is an immediate increase in the production of reactive oxygen species [7].
The weaning process represents another critical juncture, as it can induce metabolic stress, causing the animal to deplete its energy and protein reserves, culminating in the onset of OS. Oxidative stress is also related to the incidence of diseases [4] and various stressors that animals undergo from the neonatal stage to weaning, which include everything from prophylactic health measures, castration, dehorning, etc. [8]. Given that their immune and antioxidant defense systems are still immature [9], these animals are more susceptible to the occurrence of diseases and the establishment of oxidative stress.
The use of mineral supplementation and its impact on animal health and development have been a major focus of study in veterinary medicine in recent years. Among these elements, we particularly emphasize the importance of selenium (Se). The role of this trace mineral in maternal health and its impact on offspring deserves significant attention. When Se is provided to mothers during pregnancy, it can adequately meet the needs of the fetus and the newborn. This is because it is efficiently transferred to the newborn through the placenta, colostrum, and milk [10,11,12,13]. Furthermore, Se status has been established to play a crucial role in improving the rate of passive immunity transfer provided to calves through the consumption of maternal immunoglobulins found in the colostrum [14].
However, in most of the studies mentioned above, Se was provided to the animals through their diet. It is known that, when Se is administered orally to ruminants, absorption occurs primarily in the duodenum, where it can be reduced to insoluble compounds. Therefore, Se absorption in ruminants by this method is considered less effective compared to non-ruminant’s absorption capacity [15]. Therefore, parenteral administration of diphenyl diselenide (PhSe)2 provides a viable alternative to the use of more traditional forms of Se available on the market [16]. Our research team investigated the distribution of this compound in sheep. The results showed that its subcutaneous application is safe, even when administered in varying doses. This is because diphenyl diselenide did not induce any signs of toxicity in animals subjected to various treatments [17]. Based on the information provided in this study, we began an investigation of the use of this molecule as an alternative mineral supplement to that typically used. The aim is to use it during challenging and strategic periods within various ruminant production systems.
Diphenyl diselenide (PhSe)2 is an organic Se analog with numerous pharmacological properties previously documented in the literature. Its therapeutic potential is derived from its antioxidant characteristics [18], and its importance for human health has also been confirmed due to its antioxidant and anti-inflammatory properties [19]. However, in studies involving various animal species, (PhSe)2 has shown numerous functions, including cardioprotective properties by reducing hypercholesterolemia and OS in rabbits [20] and inhibiting the oxidation of low-density lipoproteins in vitro [21]. It has also shown hepatoprotective properties [22] and thwarted OS triggered by septicemia in rats [23].
Furthermore, it showed a neuroprotective effect against methylmercury-induced toxicity in mice [24] and showed fungicidal properties in rabbits infected with Pythium insidiosum [25]. (PhSe)2 antioxidant properties have been clarified in studies of fish exposed to herbicides [26] and in studies of quails, as evidenced by the superior quality of their meat [27]. It has also shown immunomodulatory effects and anti-inflammatory potential through experimental models of parasitic infections and liver damage in mice [28,29].
Despite numerous studies showing the beneficial effects of diphenyl diselenide (PhSe)2 on various animal species, its use in livestock is rarely explored in research. In dairy cattle, studies are yet to evaluate whether supplementing pregnant females with (PhSe)2 significantly affects the health and development of their calves. Therefore, this study aimed at assessing the impact of maternal supplementation with (PhSe)2, strategically administered during the prepartum period; the development, biochemical, and immune parameters; and the oxidative status of Holstein calves from the neonatal stage to weaning.

2. Materials and Methods

2.1. Ethic Committee on Animal Use

The animal study protocol was approved by the Ethic Committee on Animal Use of the Federal University of Santa Maria (UFSM) under the process number 8663120721 on 5 October 2021.

2.2. Animals, Experimental Design, and Diet

The study involved eighteen Holstein calves (n = 18, consisting of eleven females and seven males), with an age range of 1–70 days old, specifically from the neonatal period to the weaning stage. These animals are the offspring of eighteen cows that received or did not receive diphenyl diselenide (PhSe)2 supplementation during the prepartum period. The eighteen dams chosen for the study were multiparous Holstein cows, with a body condition score ranging from 3 to 3.75 (where 1 indicates thin and 5 indicates obese) and an average daily milk production of approximately 35 L during their previous lactation period.
Initially, the cows underwent a physical examination [30] prior to inclusion in the study to evaluate their health status. This ensured that animals with clinical disorders were not selected. No changes were implemented in the management or diet of the animals; therefore, they adhered to the standard farm routine. They were housed in a compost barn system throughout the prepartum period, and their diet consisted of corn silage, ryegrass hay, concentrated feed, vitamin and mineral supplements (Table 1), and water provided ad libitum. Furthermore, there were no complications during pregnancy, and all calves were born during normal delivery.
The eighteen (n = 18) calves involved in the study were part of the three groups that correspond to the treatments their mothers received. These eighteen females were subjected to three different treatments on days 42, 28, and 14 before giving birth. Six cows in the diphenyl diselenide (DDG) group were administered 3 μmol/kg of (PhSe)2 diluted in 4 mL of dimethyl sulfoxide (DMSO) (n = 6), while the DMSO (n = 6) and NaCl (n = 6) groups were administered 4 mL of DMSO and a 0.9% NaCl solution, respectively. All treatments were administered via subcutaneous (SC) route. Therefore, six calves (three females and three males) born to mothers who received (PhSe)2 supplementation were assigned to the DD group (n = 6), while the rest belonged to the DMSO group (DMSOG) (n = 6), consisting of three females and three males, and the NACL group (NACLG) (n = 6), which included five females and one male.
The calves were accommodated in individual suspended stalls immediately after birth and remained there for the entire duration of the experimental period. Colostrum was administered with fresh colostrum, obtained from their respective mothers, in a volume equivalent to 15% of their live weight within the first 6 h of life. The colostrum was assessed using a Brix refractometer (model BTX-1, Vee Gee® Scientific, Vernon Hills, IL, USA), and immunoglobulin G (IgG) concentrations (Table 2) were determined using a sandwich ELISA [31].
The diet consisted of providing a 6-L bottle of milk at 37 °C, divided into two servings per day, together with a concentrate, vitamin and mineral supplements (Table 3), and water ad libitum. Furthermore, ryegrass hay (Lolium multiflorum) was available to animals from 10 days of age. The calves, along with their mothers, did not undergo any changes in diet or management. The pre-established routine on the farms was followed throughout the study.

2.3. Diphenyl Diselenide (PhSe)2

(PhSe)2, 98% were obtained from Sigma-Aldrich® (catalog no. 180629, St. Louis, MO, USA) and diluted in dimethyl sulfoxide (DMSO) (C2H6SO; 99.2%) at the time of administration.

2.4. Execution Period and Location

The study was carried out on two commercial dairy farms from October 2021 to August 2022, with a specified execution period between December and March, in response to the observed heat stress during the summer months. The farms are located in the western region of Santa Catarina state, Brazil, known for its humid subtropical climate.

2.5. Evaluation and Sample Collection

The calves underwent weighing, measurement of withers height, and evaluation of the body condition score (BCS) 24 h after birth (day 0) on days 14, 28, 42, 56, and 70 of their life. Blood samples were collected at the same intervals via jugular venipuncture with a 21 G needle using a vacuum collection system (BD Vacutainer®, Franklin Lakes, NJ, USA) in a tube without an anticoagulant (9 mL).

2.6. Blood Tests

Serum biochemical variables, such as total protein (TP), albumin (ALB), and gamma-glutamyl transferase (GGT), were identified using an automatic biochemical analyzer (BS 230, Mindray®, Mahwah, NJ, USA) and commercial kits (Bioclin®, Belo Horizonte, MG, Brazil). The values of globulin (GLOB) and ALB:GLOB ratio (A:G) were determined by calculating the difference between the TP and ALB values (TP-ALB = GLOB) and by dividing the ALB by GLOB fractions (ALB/GLOB = A:G), respectively.
Immunoglobulin G concentrations were assessed in serum samples with sandwich ELISA [31]. The levels of thiobarbituric acid reactive substances (TBARS) [32] and reduced glutathione (GSH) [33] were also measured in serum samples.

2.7. Statistical Analysis

The assumptions of normality, homoscedasticity, and independence of residuals were previously tested using the Shapiro–Wilk test. Variables that did not have a normal distribution (GGT and IgG) were transformed. The Box-Cox transformation was applied to the GGT variable (λ = −0.5), and the natural logarithm transformation was performed on the IgG variable [34]. The response variables were analyzed using a linear model, with repeated measurements over time, satisfying the following statistical model: Yijkl = µ + TREATi + MOMENTj + (TREAT × MOMENT)ij + εijkl; where: Yijkl = response variables; μ = general average of all observations; TREATi = treatments (NACLG, DMSOG, DDG); MOMENTj = evaluation moments (0, 14, 28, 42, 56, and 70 days of life); (TREAT × MOMENT)ij = effect of the interaction between treatments and the moment of assessment; εijkl = random error associated with each observation, being ~NID (0, σ ε 2 ). If there was a statistical difference, the Tukey mean comparison test was performed. For this purpose, the statistical program R Studio® (R CORE TEAM, 2013, Vienna, Austria) was used with a significance level of 5%. Data were presented as averages and standard errors.

3. Results and Discussion

To find viable solutions to alleviate the challenges faced by calves from the neonatal stage to weaning, this study implemented maternal supplementation with organic Se, specifically in the form of (PhSe)2, during the prepartum period. The study then evaluated the impact of this supplementation on the health and development of calves. It is widely recognized that calves face numerous challenges from the moment of birth, including adapting to the environment outside the womb and the need to acquire immunoglobulins by consuming maternal colostrum. These factors, coupled with a still developing immune system, make them susceptible to diseases that typically manifest during the breastfeeding stage [35].
Se is a vital component of 20 to 25 selenoproteins in vertebrates [36], in particular, iodothyronine deiodinase, thioredoxin reductase (TrxR), and glutathione peroxidase (GPx) [37]. The TrxR and GPx enzymes perform antioxidant functions, while iodothyronine deiodinase controls the production of the active T3 hormone (triiodothyronine) in peripheral tissues and the thyroid, which contributes to animal metabolism and growth [38]. Therefore, Se plays a crucial role in the development of young animals, particularly during the initial stages of growth [39]. This fact underscores the importance of this element for calves.
The monitored development parameters showed that the animals in the NaCl group experienced a greater weight gain (Figure 1; p = 0.002) compared to those in the DMSO group on days 42, 56, and 70 of their life. There were no statistical differences between the groups regarding withers height (Figure 1; p > 0.05), but the BCS (Figure 1) showed interaction between treatments (p = 0.020), with the NACLG presenting lower values for this evaluation in two moments (days 0 and 14) when compared with DMSOG. However, a significant increase in body weight (p < 0.001) and height at the withers (p < 0.001) was observed on different days within all groups for almost the entire experimental period. In the BCS assessment, there was a significant increase from days 0 and 14 to 70 within the NaCl group (p < 0.001). We believe that these results stem from the uniform development exhibited by the calves involved in the study, which occurred regardless of the treatment their mothers underwent. In another study, our research team observed positive outcomes in the weaning weight (on the 70th day of life) of female Holstein calves when (PhSe)2 was administered from birth until weaning [40], similarly to a previous study [41], which also reported a significant weight gain on the 270th day of life after administering (PhSe)2 to Holstein calves aged 50 to 70 days. However, in both studies, the administrations were performed directly on the calves, unlike in this study, where we used maternal supplementation with (PhSe)2 during the prepartum period. On the other hand, when we compare the immunological responses triggered by maternal supplementation and direct administration to calves, the results are similar. Because we found a significant increase in IgG in calves born to cows subjected to supplementation with (PhSe)2 and because of results from a previous study, calves subjected to supplementation also showed an increase in this variable [40].
In this study, total protein, albumin, gamma-glutamyl transferase, and immunoglobulin G measurements were performed, as these variables are critical to evaluate the success or failure of passive immunity transfer in calves. These animals are known to have agammaglobulinemia due to the characteristics of the syndesmochorial placenta of female bovines. This placenta separates maternal and fetal blood supplies, preventing the transfer of immunoglobulins. As a result, newborns rely on maternal colostral immunoglobulin ingestion for their protection immediately after birth [2].
The DD group showed interaction treatment x moment to TP (Figure 2; p = 0.049) and GLOB (Figure 2; p = 0.038). Furthermore, DDG showed the highest average levels of TP (p = 0.002), ALB (Figure 2; p = 0.043), and GLOB (p = 0.007) on day 0 compared to the other experimental groups. The same pattern can be observed in the TP (p = 0.003) and GLOB (p < 0.001) values within the DD group when comparing day 0 with other experimental time points (14, 28, 42, 56, and 70). In the evaluation of ALB within the groups, the lowest averages were observed near the birth date (day 0). The DD group showed a significant increase in ALB (p < 0.001) from day 0 to days 42, 56, and 70 and again from day 14 to days 56 and 70. The A:G ratio (Figure 2) did not indicate any differences between treatments (p > 0.05). However, there was a significant increase (p < 0.001) within the groups from birth (day 0) to subsequent time points (14, 28, 42, 56, and 70 days) and in the DD group from day 14 to days 42, 56, and 70.
The significant findings of TP, ALB, and GLOB in the DD group, observed immediately after colostrum feeding, were attributed to the absorption of colostral immunoglobulins, which increased subsequently in protein fractions. When we collectively examined the TP results and serum IgG concentrations on day 0, it can be said that all calves involved in the study achieved excellent levels of passive immunity transfer. Because the proposed standard for evaluation of immunity passive transfer includes four categories: excellent (IgG ≥ 25.0 g/L and TP ≥ 6.2 g/dL), good (IgG 18.0–24.9 g/L and TP 5.8–6.1 g/dL), fair (IgG 10–17.9 g/L and TP 5.1–5.7 g/dL), and poor (IgG < 10.0 g/L and TP < 5.1 g/dL), these categories can be applied to individual calves and to the operation for herd-based evaluation based on the percentage of calves that should be represented in each category [2]. The quality of the provided colostrum also contributed to the positive outcomes observed since all mother groups showed colostral brix and IgG values considered high quality (Table 2), specifically a brix index ≥ 22% and an IgG concentration ≥ 50 g/L [2].
A GGT measurement has been used as an alternative and indirect method to assess the transfer of passive immunity. This is because this enzyme is found in high concentrations in the colostrum of ruminants; therefore, its activity increases in calves that have received the appropriate intake of colostrum [42]. In our study, GGT concentrations (Figure 2) did not show significant differences between the groups (p > 0.05). However, when comparing days, the NACL and DD groups showed the highest concentrations on day 0 (p < 0.001) compared to days 28, 42, 56, and 70. These results were expected due to the colostrum feeding protocol that the animals underwent during the experimental period. When we collectively evaluate the TP, GGT, and IgG data from the calves, we can affirm that passive immunity transfer was carried out successfully.
IgG levels (Figure 2) in the DD group were significantly higher (p < 0.001) than those in the other groups (NACL and DMSO) on days 0, 14, 56, and 70. In the DD group, there was a significant decrease in their concentrations from day 0 to days 28 and 42, followed by a significant increase from days 28 and 42 to day 70 (p = 0.008). We believe that (PhSe)2 contributed to the increase in Se bioavailability in the bodies of cows and, consequently, in their calves through the transplacental pathway and through the ingestion of colostrum with higher concentrations of this mineral due to the supplementation received by the mothers.
Despite already being described in the literature that providing organic and, thus, more bioavailable forms of selenium to pregnant females improves the Se status of calves [43,44,45], until now, (PhSe)2 was used in few studies as an organic source for selenium supplementation in cattle. Therefore, it is necessary to conduct more research to evaluate the bioavailability, nutritional value, deposition, and body functions of alternative Se sources in different breeds and physiological stages of cattle raised in areas with different Se levels [46]. Selenium bioavailability also improves the absorption efficiency of IgG, subsequently increasing its serum concentration [47]. This is because Se availability is closely related to the process of pinocytosis, the mechanism by which immunoglobulins are absorbed into the intestinal epithelium [48].
It is also interesting to note that Se (as component of specific selenoproteins) has a direct role in the process of endocytosis in macrophages [49]. Accordingly, recent studies with different types of formulations containing Se have indicated a positive effect of supplementation in both pinocytosis and phagocytosis in macrophages and other mammalian cell types [50]. Of particular health importance to the calves and to our present findings, the supplementation of Se (in alfalfa Se-enriched diets) to the dams improved the pinocytosis of newborn calves (as determined by the passive transfer of ovoalbumin) in a concentration-dependent manner [14]. In accordance, the addition of selenium to the colostrum given to calves just after the partum significantly increased the calves IgG level for up two weeks; the authors suggested that Se supplementation can improve the pinocytosis in new born calves, and this specific case shows that the effect of Se on IgG absorption is not only nutritional but also has pharmacological potential [47]. When (PhSe)2 was administered to Holstein calves, we observed a significant increase in IgG concentrations from the neonatal stage to weaning. Furthermore, we observed a reversal in the IgG trend. In the control group, there was a gradual decrease in age progression, while the treated animals showed an increase [40].
When examining IgG values among all groups, we observed a similar pattern between them, marked by a significant drop at 28 and 42 days of life. This physiological decline, known as the immunological window, occurs due to a decrease in the concentration of immunoglobulins ingested through the colostrum, which are responsible for providing passive immunity to the newborn. This decrease is likely due to the plasma half-life of IgG, approximately 21 days [51]. Simultaneously, the active immune system of the calf has not yet reached full maturity [52].
Shortly after this decline, the DD group exhibited a substantial increase in IgG concentrations compared to the other groups at 56 and 70 days of age. We attribute this increase to the previously documented ability of (PhSe)2 to accumulate in deeper tissues, such as the liver, kidneys, and brain, and gradually distribute in the bloodstream [17]. Therefore, we believe that (PhSe)2 remained in storage sites and, through its continuous release, contributed to the development of humoral immunity in calves. This is because IgG constitutes 85% of the γ globulin fraction, which is composed of immunologically active substances (immunoglobulins A, M, E, and G) and plays a crucial role in antibody formation [53].
Immunoglobulins, produced by plasma cells, are considered the primary components of humoral immunity. Furthermore, research suggests that Se can enhance the synthesis of antibodies and immunoglobulins, indicating its significant role in IgG production [46]. Additionally, the stimulation of immune function initiated by this mineral through the proliferation of T cells and activation of natural killer (NK) cells is also well established [54]. This leads us to conclude that organic Se supplementation, i.e., (PhSe)2, improved the immune function of the animals. Another crucial aspect is that the use of organic Se sources is more effective than that of inorganic sources. This is because organic Se has a greater capacity to enhance the expression of hepatic and muscular selenoprotein genes [55]. In addition, it can efficiently stimulate lymphocytes to secrete cytokines, signaling the initiation of humoral immunity and, subsequently, leading to the production of immunoglobulins [56].
Although the exact mechanisms involved in the increase in IgG levels in calves caused by (PhSe)2 administration to the dams is unknown, the immunostimulatory effects of different chemical forms of selenium have been frequently described in the literature (for a comprehensive review see [49] and the references therein). In effect, the stimulation of different selenoprotein synthesis by diphenyl diselenide [57] can contribute to the immunostimulant effects observed in Holstein calves born from supplemented cows. In addition, by modulating the anti-inflammatory and antioxidant pathways [58], diphenyl diselenide can also indirectly improve the general health of calves.
Elevated levels of TBARS (Figure 3) were observed in the DD group on day 0 compared to the other groups (p = 0.010). The DD group showed the highest concentrations on the day of birth (day 0), followed by a significant reduction (p < 0.001) on days 28, 42, 56, and 70. The elevated lipid peroxidation activity observed in the DD group on day 0 is probably the result of stress induced by birth, resulting from the initial exposure to the extrauterine environment. However, it should be noted that while minerals can exhibit antioxidant properties, they can also function as pro-oxidants [9]. We understand that the Se requirement, as stated in the literature for all categories of dairy cattle, is 300 µg/kg of dry matter (DM) [59]. However, in this study, we are unaware of the Se status of the cows at the time of administration. We must also consider the possibility that supplementation with (PhSe)2 may have helped generate reactive species in the DD group on day 0.
One of the primary therapeutic characteristics of (PhSe)2 is derived from its antioxidant potential, as it simulates the activity of the GPx enzyme [18]. In this study, we measured the concentrations of GSH since it is crucial for GPx to decompose hydrogen peroxide into water. GSH serves as an electron donor, producing oxidized glutathione (GSSG). To maintain its antioxidant activity, GSSG is reconverted to GSH through the action of glutathione reductase (GR) [60]. Therefore, by quantifying GSH, we indirectly infer the activity of GPx. However, GSH (Figure 3) did not show significant differences between treatments and between different days within the groups (p > 0.05). However, we did not identify a specific antioxidant response to maternal prepartum supplementation with (PhSe)2. One point that we have to highlight here is the absence of reference values for TBARS and GSH for this specific animal category. The absence of clinically validated normal values for those markers limit the importance of our data related to them. Furthermore, it would be important to develop the standard values of those two biochemical biomarkers of the redox state of Holstein calves.

4. Conclusions

Maternal supplementation during the prepartum period with organic Se, administered in this study as diphenyl diselenide (PhSe)2, contributed to the outstanding rates of passive immunity transfer observed and to the initiation and improvement of calves’ humoral immunity. Our findings are based on the detected concentrations of TP, ALB, GLOB, and IgG in the DD group immediately after colostrum collection and on the behavior of IgG, which showed elevated levels compared to other groups from the neonatal stage to weaning, with a physiological decrease observed only during the immunological window period.
Therefore, our research offers fresh insights into one of the numerous effects of (PhSe)2, specifically its immunomodulatory potential. This characteristic increasingly positions it as a viable alternative to address this challenging phase of the dairy cattle production process, specifically calf rearing. We highlighted that, in our study, (PhSe)2 was administered subcutaneously, ensuring that the animals received the prescribed dosage accurately. We also emphasize its safe use because it can be easily used without any risk of toxicity during the challenging and strategic phases of the production system. Furthermore, our findings also showed the importance of providing this trace mineral to pregnant cows, particularly during the prepartum phase, and its capacity to be effectively absorbed by calves through the placenta and colostrum, thus significantly improving their immune system.

Author Contributions

Conceptualization, C.M.R. and M.L.d.R.L.; methodology, C.M.R., S.G.C. and M.L.d.R.L.; validation, C.M.R. and M.L.d.R.L.; formal analysis, C.M.R. and M.L.d.R.L.; investigation, C.M.R., E.B.P., K.W.L., M.S. and S.G.C.; resources, M.S., S.G.C., F.W.S.C., V.G., M.G.B., J.B.T.d.R. and M.L.d.R.L.; data curation, C.M.R. and M.L.d.R.L.; writing—original draft preparation, C.M.R.; writing—review and editing, C.M.R. and M.L.d.R.L.; visualization, C.M.R. and M.L.d.R.L.; supervision, M.L.d.R.L.; project administration, C.M.R. and M.L.d.R.L.; funding acquisition, M.L.d.R.L. All authors have read and agreed to the published version of the manuscript.

Funding

This study was financed in part by the Coordination for the Improvement of Higher Education Personnel (CAPES)—Finance Code 001.

Institutional Review Board Statement

The animal study protocol was approved by the Ethic Committee on Animal Use of the Federal University of Santa Maria (UFSM), under the process number 8663120721, in 5 October 2021.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding authors (C.M.R. and M.L.R.L.).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Vogels, Z.; Chuck, G.; Morton, J. Failure of transfer of passive immunity and agammaglobulinaemia in calves in south-west Victorian dairy herds: Prevalence and risk factors. Aust. Vet. J. 2013, 91, 150–158. [Google Scholar] [CrossRef] [PubMed]
  2. Godden, S.M.; Lombard, J.E.; Woolums, A.R. Colostrum management for dairy calves. Vet. Clin. N. Am. 2019, 35, 535–556. [Google Scholar] [CrossRef] [PubMed]
  3. Beam, A.L.; Lombard, J.E.; Kopral, C.A.; Garber, L.P.; Winter, A.L.; Hicks, J.A.; Schlater, J.L. Prevalence of failure of passive transfer of immunity in newborn heifer calves and associated management practices on US dairy operations. J. Dairy Sci. 2009, 92, 3973–3980. [Google Scholar] [CrossRef] [PubMed]
  4. Abuelo, A.; Hernández, J.; Benedito, J.; Castillo, C. Redox biology in transition periods of dairy cattle: Role in the health of periparturient and neonatal animals. Antioxidants 2019, 8, 20. [Google Scholar] [CrossRef] [PubMed]
  5. Castillo, C.; Hernandez, J.; Bravo, A.; Lopez-Alonso, M.; Pereira, V.; Benedito, J.L. Oxidative status during late pregnancy and early lactation in dairy cows. Vet. J. 2005, 169, 286–292. [Google Scholar] [CrossRef] [PubMed]
  6. Biri, A.; Bozkurt, N.; Turp, A.; Kavutcu, M.; Himmetoglu, Ö.; Durak, İ. Role of oxidative stress in intrauterine growth restriction. Gynecol. Obstet. Investig. 2007, 64, 187–192. [Google Scholar] [CrossRef] [PubMed]
  7. Saugstad, O.D. Oxygen toxicity at birth: The pieces are put together. Pediatr. Res. 2003, 54, 789. [Google Scholar] [CrossRef]
  8. Inanami, O.; Shiga, A.; Okada, K.; Sato, R.; Miyake, Y.; Kuwabara, M. Lipid peroxides and antioxidants in serum of neonatal calves. Am. J. Vet. Res. 1999, 60, 452–457. [Google Scholar]
  9. Celi, P. Biomarkers of oxidative stress in ruminant medicine. Immunopharmacol. Immunotoxicol. 2010, 33, 233–240. [Google Scholar] [CrossRef]
  10. Rock, M.J.; Kincaid, R.L.; Carstens, G.E. Effects of prenatal source and level of dietary selenium on passive immunity and thermometabolism of newborn lambs. Small Rumin. Res. 2001, 40, 129–138. [Google Scholar] [CrossRef]
  11. Ghany-Hefnawy, A.E.; López-Arellano, R.; Revilla-Vázquez, A.; Ramírez-Bribiesca, E.; Tórtora-Pérez, J. The relationship between fetal and maternal selenium concentrations in sheep and goats. Small Rumin. Res. 2007, 73, 174–180. [Google Scholar] [CrossRef]
  12. Stewart, W.C.; Bobe, G.; Vorachek, W.R.; Stang, B.V.; Pirelli, G.J.; Mosher, W.D.; Hall, J.A. Organic and inorganic selenium: IV. Passive transfer of immunoglobulin from ewe to lamb. J. Anim. Sci. 2013, 91, 1791–1800. [Google Scholar] [CrossRef] [PubMed]
  13. Schomburg, L.; Schweizer, U.; Köhrle, J. Selenium and selenoproteins in mammals: Extraordinary, essential, enigmatic. Cell. Mol. Life Sci. 2004, 61, 1988–1995. [Google Scholar] [CrossRef] [PubMed]
  14. Apperson, K.D.; Vorachek, W.R.; Dolan, B.P.; Bobe, G.; Pirelli, G.J.; Hall, J.A. Effects of feeding pregnant beef cows selenium-enriched alfalfa hay on passive transfer of ovalbumin in their newborn calves. J. Trace Elem. Med. Biol. 2018, 50, 640–645. [Google Scholar] [CrossRef] [PubMed]
  15. McDowell, L.R. Feeding minerals to cattle on pasture. Anim. Feed Sci. Technol. 1996, 60, 247–271. [Google Scholar] [CrossRef]
  16. Prauchner, C.A. The Importance of Selenium for Agriculture and Human Health, 1st ed.; Publisher of the Federal University of Santa Maria: Santa Maria, RS, Brazil, 2020; pp. 256–261. [Google Scholar] [CrossRef]
  17. Leal, M.L.R.; Rocha, J.B.T.; Corte, C.L.D.; Aires, A.R.; Rocha, J.F.X.; Zanatta, R.S.; Carpes, J.L.S.; Szinwelski, G.A.; Stefanello, S.; Pivoto, F.L. Distribution of selenium in sheep treated with diphenyl diselenide. Arq. Bras. Med. Vet. Zootec. 2018, 70, 1017–1022. [Google Scholar] [CrossRef]
  18. Meotti, F.C.; Stangherlin, E.C.; Zeni, G.; Nogueira, C.W.; Rocha, J.B.T. Protective role of aryl and alkyl diselenides on lipid peroxidation. Environ. Res. 2004, 94, 276–282. [Google Scholar] [CrossRef] [PubMed]
  19. Pappas, A.C.; Zoidis, E.; Chadio, S.E. Maternal selenium and developmental programming. Antioxidants 2019, 8, 145. [Google Scholar] [CrossRef]
  20. De Bem, A.F.; de Lima Portella, R.; Colpo, E.; Duarte, M.M.M.F.; Frediane, A.; Taube, P.S.; Nogueira, C.W.; Farina, M.; da Silva, E.L.; Teixeira Rocha, J.B. Diphenyl diselenide decreases serum levels of total cholesterol and tissue oxidative stress in cholesterol-fed rabbits. Basic Clin. Pharmacol. Toxicol. 2009, 105, 17–23. [Google Scholar] [CrossRef]
  21. De Bem, A.F.; Farina, M.; de Lima Portella, R.; Nogueira, C.W.; Dinis, T.C.P.; Laranjinha, J.A.N.; Almeida, L.M.; Rocha, J.B.T. Diphenyl diselenide, a simple glutathione peroxidase mimetic, inhibits human LDL oxidation in vitro. Atherosclerosis 2008, 201, 92–100. [Google Scholar] [CrossRef]
  22. Costa, M.D.; de Freitas, M.L.; Dalmolin, L.; Oliveira, L.P.; Fleck, M.A.; Pagliarini, P.; Acker, C.; Roman, S.S.; Brandão, R. Diphenyl diselenide prevents hepatic alterations induced by paraquat in rats. Environ. Toxicol. Pharmacol. 2013, 36, 750–758. [Google Scholar] [CrossRef] [PubMed]
  23. Prauchner, C.A.; Prestes, A.D.S.; da Rocha, J.B.T. Effects of diphenyl diselenide on oxidative stress induced by sepsis in rats. Pathol. Res. Pract. 2011, 207, 554–558. [Google Scholar] [CrossRef] [PubMed]
  24. Glaser, V.; Moritz, B.; Schmitz, A.; Dafré, A.L.; Nazari, E.M.; Rauh Müller, Y.M.; Feksa, L.; Straliottoa, M.R.; de Bem, A.F.; Farina, M.; et al. Protective effects of diphenyl diselenide in a mouse model of brain toxicity. Chem. Biol. Interact. 2013, 206, 18–26. [Google Scholar] [CrossRef] [PubMed]
  25. Loreto, É.S.; Alves, S.H.; Santurio, J.M.; Nogueira, C.W.; Zeni, G. Diphenyl diselenide in vitro and in vivo activity against the oomycete Pythium insidiosum. Vet. Microbiol. 2012, 156, 222–226. [Google Scholar] [CrossRef]
  26. de Menezes, C.C.; Leitemperger, J.; Santi, A.; Lópes, T.; Aline Veiverberg, C.; Peixoto, S.; Bohrer Adaime, M.; Zanella, R.; Vargas Barbosa, N.B.; Lucia Loro, V. The effects of diphenyl diselenide on oxidative stress biomarkers in Cyprinus carpio exposed to herbicide quinclorac (Facet®). Ecotoxicol. Environ. Saf. 2012, 81, 91–97. [Google Scholar] [CrossRef]
  27. Roza, L.d.F.; da Silva, A.S.; Migliorini, M.J.; Bottari, N.B.; Glombowsky, P.; Baretta, M.; Tavernari, F.d.C.; Stefani, L.M.; Boiago, M. Adding diphenyl diselenide in the diets of quails improves the quality of meat. Rev. MVZ Cordoba 2018, 23, 6964–6973. [Google Scholar] [CrossRef]
  28. Stefanello, S.T.; da Rosa, E.J.F.; Dobrachinski, F.; Amaral, G.P.; de Carvalho, N.R.; da Luz, S.C.A.; Bender, C.R.; Schwab, R.S.; Dornelles, L.; Soares, F.A.A. Effect of diselenide administration in thioacetamide-induced acute neurological and hepatic failure in mice. Toxicol. Res. 2015, 4, 707–717. [Google Scholar] [CrossRef]
  29. Doleski, P.H.; Ten Caten, M.V.; Passos, D.F.; Castilhos, L.G.; Leal, D.B.R.; Machado, V.S.; Bottari, N.B.; Vogel, F.F.; Mendes, R.E.; da Silva, A.S. Toxoplasmosis treatment with diphenyl diselenide in infected mice modulates the activity of purinergic enzymes and reduces inflammation in spleen. Exp. Parasitol. 2017, 181, 7–13. [Google Scholar] [CrossRef]
  30. Dirksen, G.; Gründer, H.D.; Stöber, M. Clinical Examination of Cattle, 3rd ed.; Guanabara Koogan: Rio de Janeiro, RJ, Brazil, 1993; pp. 44–80. [Google Scholar]
  31. Reber, A.J.; Donovan, D.C.; Gabbard, J.; Galland, K.; Aceves-Avila, M.; Holbert, K.A.; Marshall, L.; Hurley, D.J. Transfer of maternal colostral leukocytes promotes development of the neonatal immune system. Vet. Immunol. Immunopathol. 2008, 123, 305–313. [Google Scholar] [CrossRef]
  32. Ohkawa, K. Promotion of renewal canes in greenhouse roses by 6-benzylamino purine without cutback. HortScience 1979, 14, 612–613. [Google Scholar] [CrossRef]
  33. Ellman, G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82, 70–77. [Google Scholar] [CrossRef]
  34. Sakia, R.M. The box-cox transformation technique: A review. Statistician 1992, 41, 169–178. [Google Scholar] [CrossRef]
  35. Gomes, V.; Madureira, K.M.; Borges, J.R.J.; Pinheiro, F.A.; Martin, C.C.; Baccili, C.C.; Santos, J.F.; Yasuoka, M.M.; Decaris, N.; Bombardelli, J.A.; et al. Pre-weaning diseases and calf health management practices. Rev. Bras. Buiat. 2021, 1, 27–62. [Google Scholar] [CrossRef]
  36. Lobanov, A.V.; Hatfield, D.L.; Gladyshev, V.N. Eukaryotic selenoproteins and selenoproteomes. Biochim. Biophys. Acta 2009, 1790, 1424–1428. [Google Scholar] [CrossRef]
  37. Ou, B.; Huang, D.; Hampsch-Woodill, M.; Flanagan, J.A.; Deemer, E.K. Analysis of antioxidant activities of common vegetables employing oxygen radical absorbance capacity (ORAC) and ferric reducing antioxidant power (FRAP) assays: A comparative study. J. Agric. Food Chem. 2002, 50, 3122–3128. [Google Scholar] [CrossRef]
  38. Rooke, J.A.; Robinson, J.J.; Arthur, J.R. Effects of vitamin E and selenium on the performance and immune status of ewes and lambs. J. Agric. Sci. 2004, 142, 253–262. [Google Scholar] [CrossRef]
  39. Ganie, A.A.; Baghel, R.P.S.; Mudgal, V.; Shelkh, G.G. Effect of selenium supplementation on growth and nutrient utilization in buffalo heifers. Anim. Nutr. Feed Technol. 2010, 10, 255–259. Available online: https://www.researchgate.net/publication/326113102_Effect_of_Selenium_Supplementation_on_Growth_and_Nutrient_Utilization_in_Buffalo_Heifers (accessed on 10 October 2023).
  40. Rodrigues, C.M.; Schneider, M.; de Oliveira, J.S.; Collet, S.G.; Camillo, G.; Duarte, M.M.M.F.; Rocha, J.B.T.d.; Andrade, C.M.d.; Blagitz, M.G.; Leal, M.L.d.R. Does diphenyl diselenide metaphylaxis increase weight gain and immunoglobulin G in holstein calves from the neonatal period to weaning? Agric. Acad. J. 2020, 3, 49–61. [Google Scholar] [CrossRef]
  41. Santos, D.S.D.; Boito, J.P.; Klauck, V.; Reis, J.H.D.; Gebert, R.R.; Glombowsky, P.; Biazus, A.H.; Bottari, N.B.; Sousa, R.S.; Machado, G.; et al. Health benefits of subcutaneous zinc edetate and diphenyl diselenide in calves during the weaning period. An. Acad. Bras. Cienc. 2019, 91, 1–12. [Google Scholar] [CrossRef]
  42. Fagliari, J.J.; Santana, A.E.; Lucas, F.A.; Campos Filho, E.; Curi, P.R. Blood constituents of the newborn Nelore cattle (Bos indicus), Holstein cattle (Bos Taurus), and Murrah buffalo (Bubalus bubalis). Arq. Bras. Med. Vet. Zootec. 1998, 50, 253–262. Available online: https://repositorio.unesp.br/server/api/core/bitstreams/b06a7772-8418-4b55-819d-4cee67d1ac57/content (accessed on 15 October 2023).
  43. Pehrson, B.; Ortman, K.; Madjid, N.; Trafikowska, U. The influence of dietary selenium as selenium yeast or sodium selenite on the concentration of selenium in the milk of Suckler cows and on the selenium status of their calves. J. Anim. Sci. 1999, 77, 3371–3376. [Google Scholar] [CrossRef] [PubMed]
  44. Gunter, S.A.; Beck, P.A.; Phillips, J.M. Effects of supplementary selenium source on the performance and blood measurements in beef cows and their calves. J. Anim. Sci. 2003, 81, 856–864. [Google Scholar] [CrossRef]
  45. Guyot, H.; Spring, P.; Andrieu, S.; Rollin, F. Comparative responses to sodium selenite and organic selenium supplements in Belgian Blue cows and calves. Livest. Sci. 2007, 111, 259–263. [Google Scholar] [CrossRef]
  46. Huang, Q.; Wang, S.; Yang, X.; Han, X.; Liu, Y.; Khan, N.A.; Tan, Z. Effects of organic and inorganic selenium on selenium bioavailability, growth performance, antioxidant status and meat quality of a local beef cattle in China. Front. Vet. Sci. 2023, 10, 1171751. [Google Scholar] [CrossRef]
  47. Hall, J.A.; Bobe, G.; Vorachek, W.R.; Estill, C.T.; Mosher, W.D.; Pirelli, G.J.; Gamroth, M. Effect of supranutritional maternal and colostral selenium supplementation on passive absorption of immunoglobulin G in selenium-replete dairy calves. J. Dairy Sci. 2014, 97, 4379–4391. [Google Scholar] [CrossRef]
  48. Kamada, H.; Nonaka, I.; Ueda, Y.; Murai, M. Selenium addition to colostrum increases immunoglobulin G absorption by newborn calves. J. Dairy Sci. 2007, 90, 5665–5670. [Google Scholar] [CrossRef]
  49. Golin, A.; Tinkov, A.A.; Aschner, M.; Farina, M.; da Rocha, J.B.T. Relationship between selenium status, selenoproteins and COVID-19 and other inflammatory diseases: A critical review. J. Trace Elem. Med. Biol. 2023, 75, 127099. [Google Scholar] [CrossRef]
  50. Ning, M.; Hua, S.; Ma, Y.; Liu, Y.; Wang, D.; Xu, K.; Yu, H. Microvesicles facilitate the differentiation of mesenchymal stem cells into pancreatic beta-like cells via miR-181a-5p/150-5p. Int. J. Biol. Macromol. 2023, 254, 127719. [Google Scholar] [CrossRef]
  51. Logan, E.F.; Penhale, W.J.; Jones, R.A. Changes in the serum immunoglobulin levels of colostrum-fed calves during the first 12 weeks postpartum. Res. Vet. Sci. 1973, 14, 394–397. [Google Scholar] [CrossRef]
  52. Hulbert, L.E.; Moisá, S.J. Stress, immunity, and the management of calves. J. Dairy Sci. 2016, 99, 3199–3216. [Google Scholar] [CrossRef]
  53. Kaneko, J.J.; Harvey, J.W.; Bruss, M.L. Clinical Biochemistry of Domestic Animals, 6th ed.; Academic Press: San Diego, CA, USA, 2008; pp. 157–172. [Google Scholar] [CrossRef]
  54. Huang, Z.; Rose, A.H.; Hoffmann, P.R. The role of selenium in inflammation and immunity: From molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 2012, 16, 705–743. [Google Scholar] [CrossRef] [PubMed]
  55. Zhang, K.; Zhao, Q.; Zhan, T.; Han, Y.; Tang, C.; Zhang, J. Effect of different selenium sources on growth performance, tissue selenium content, meat quality, and selenoprotein gene expression in finishing pigs. Biol. Trace Elem. Res. 2019, 196, 463–471. [Google Scholar] [CrossRef] [PubMed]
  56. Bami, M.K.; Afsharmanesh, M.; Espahbodi, M.; Esmaeilzadeh, E. Effects of dietary nano-selenium supplementation on broiler chicken performance, meat selenium content, intestinal microflora, intestinal morphology, and immune response. J. Trace Elem. Med. Biol. 2022, 69, 126897. [Google Scholar] [CrossRef]
  57. De Bem, A.F.; Fiuza, B.; Calcerrada, P.; Brito, P.M.; Peluffo, G.; Dinis, T.C.; Trujillo, M.; Rocha, J.B.T.; Radi, R.; Almeida, L.M. Protective effect of diphenyl diselenide against peroxynitrite-mediated endothelial cell death: A comparison with ebselen. Nitric Oxide 2013, 31, 20–30. [Google Scholar] [CrossRef]
  58. Dias, G.R.M.; Golombieski, R.M.; Portella, R.L.P.; Amaral, G.P.; Soares, F.A.; Rocha, J.B.T.; Nogueira, C.W.; Barbosa, N.V. Diphenyl diselenide modulates gene expression of antioxidant enzymes in the cerebral cortex, hippocampus and striatum of female hypothyroid rats. Neuroendocrinology 2014, 100, 45–59. [Google Scholar] [CrossRef]
  59. National Research Council. Nutrient Requirements of Dairy Cattle, 8th ed.; National Academies Press: Washington, DC, USA, 2021; pp. 143–146. [Google Scholar] [CrossRef]
  60. Lu, S.C. Glutathione synthesis. Biochim. Biophys. Acta 2013, 1830, 3143–3153. [Google Scholar] [CrossRef]
Animals 14 00010 g001
Figure 1. Average ± standard error and p value of body weight (kg), withers height (cm), and body condition score of Holstein calves from birth (day 0) to 14, 28, 42, 56, and 70 days of life, born to females who were or were not submitted to supplementation with diphenyl diselenide at 42, 28, and 14 days prior to calving. The calves were distributed into groups: diphenyl diselenide (DDG), dimethyl sulfoxide (DMSOG), and NaCl (NACLG) (average ± standard error, n = 6/treatment). Distinct capital letters refer to differences (p < 0.05) between groups on the respective days, while lowercase letters refer to differences (p < 0.05) between days within groups. T = treatment effect, M = moment effect, and T × M = interaction treatment moment.
Figure 1. Average ± standard error and p value of body weight (kg), withers height (cm), and body condition score of Holstein calves from birth (day 0) to 14, 28, 42, 56, and 70 days of life, born to females who were or were not submitted to supplementation with diphenyl diselenide at 42, 28, and 14 days prior to calving. The calves were distributed into groups: diphenyl diselenide (DDG), dimethyl sulfoxide (DMSOG), and NaCl (NACLG) (average ± standard error, n = 6/treatment). Distinct capital letters refer to differences (p < 0.05) between groups on the respective days, while lowercase letters refer to differences (p < 0.05) between days within groups. T = treatment effect, M = moment effect, and T × M = interaction treatment moment.
Animals 14 00010 g001
Animals 14 00010 g002
Figure 2. Average ± standard error and p value of total protein (g/dL), albumin (g/dL), globulin (g/dL), albumin globulin ratio, gamma-glutamyl transferase (IU/L), and immunoglobulin G (g/L) of Holstein calves from birth (day 0) to 14, 28, 42, 56, and 70 days of life, born to females who were or were not submitted to supplementation with diphenyl diselenide at 42, 28, and 14 days prior to calving. The calves were distributed into groups: diphenyl diselenide (DDG), dimethyl sulfoxide (DMSOG) and NaCl (NACLG) (average ± standard error, n = 6/treatment). Distinct capital letters refer to differences (p < 0.05) between groups on the respective days, while lowercase letters refer to differences (p < 0.05) between days within groups. T = treatment effect, M = moment effect, and T × M = interaction treatment moment.
Figure 2. Average ± standard error and p value of total protein (g/dL), albumin (g/dL), globulin (g/dL), albumin globulin ratio, gamma-glutamyl transferase (IU/L), and immunoglobulin G (g/L) of Holstein calves from birth (day 0) to 14, 28, 42, 56, and 70 days of life, born to females who were or were not submitted to supplementation with diphenyl diselenide at 42, 28, and 14 days prior to calving. The calves were distributed into groups: diphenyl diselenide (DDG), dimethyl sulfoxide (DMSOG) and NaCl (NACLG) (average ± standard error, n = 6/treatment). Distinct capital letters refer to differences (p < 0.05) between groups on the respective days, while lowercase letters refer to differences (p < 0.05) between days within groups. T = treatment effect, M = moment effect, and T × M = interaction treatment moment.
Animals 14 00010 g002
Animals 14 00010 g003
Figure 3. Average ± standard error and p value of thiobarbituric acid reactive substances (nmol MDA/mL) and reduced glutathione (nmol/mL) of Holstein calves from birth (day 0) to 14, 28, 42, 56, and 70 days of life, born to females who were or were not submitted to supplementation with diphenyl diselenide at 42, 28, and 14 days prior to calving. The calves were distributed into groups: diphenyl diselenide (DDG), dimethyl sulfoxide (DMSOG), and NaCl (NACLG) (average ± standard error, n = 6/treatment). Distinct capital letters refer to differences (p < 0.05) between groups on the respective days, while lowercase letters refer to differences (p < 0.05) between days within groups. T = treatment effect, M = moment effect, and T × M = interaction treatment moment.
Figure 3. Average ± standard error and p value of thiobarbituric acid reactive substances (nmol MDA/mL) and reduced glutathione (nmol/mL) of Holstein calves from birth (day 0) to 14, 28, 42, 56, and 70 days of life, born to females who were or were not submitted to supplementation with diphenyl diselenide at 42, 28, and 14 days prior to calving. The calves were distributed into groups: diphenyl diselenide (DDG), dimethyl sulfoxide (DMSOG), and NaCl (NACLG) (average ± standard error, n = 6/treatment). Distinct capital letters refer to differences (p < 0.05) between groups on the respective days, while lowercase letters refer to differences (p < 0.05) between days within groups. T = treatment effect, M = moment effect, and T × M = interaction treatment moment.
Animals 14 00010 g003
Table 1. Composition of the diet fed to pre-partum Holstein cows who were or were not submitted to supplementation with diphenyl diselenide at 42, 28, and 14 days prior to calving and distributed in groups: diphenyl diselenide (DDG), dimethyl sulfoxide (DMSOG), and NaCl (NACLG).
Table 1. Composition of the diet fed to pre-partum Holstein cows who were or were not submitted to supplementation with diphenyl diselenide at 42, 28, and 14 days prior to calving and distributed in groups: diphenyl diselenide (DDG), dimethyl sulfoxide (DMSOG), and NaCl (NACLG).
IngredientValues
Corn silage (% DM 2)64.07
Ryegrass hay (% DM 2)12.00
Soybean meal (% DM 2)11.23
Soybean hulls (% DM 2)10.63
Premix of vitamins and minerals 1 (% DM 2)2.07
Chemical composition
DM 2 (%)49.8
CP 3 (% DM 2)11.3
ADF 4 (% DM 2)26.5
NDF 5 (% DM 2)42.6
Starch (% DM 2)23.3
Fatty acids (% DM 2)3.42
Ca 6 (% DM 2)0.51
P 7 (% DM 2)0.31
ME 8 (Mcal/kg)2.57
NEL 9 (Mcal/kg)1.70
Se 10 (mg/kg)0.41
1 Minimal vitamin and mineral levels per kg of product: vitamin A (480,000 UI); vitamin D3 (200,000 UI); vitamin E (12,000 UI); calcium (106 g); phosphorus (30 g); sulfur (90 g); magnesium (20 g); sodium (31 g); chlorine (130 g); cobalt (12 mg); cooper (600 mg); chromium (30 mg); iron (600 mg); iodine (60 mg); manganese (1600 mg); selenium (16 mg); zinc (2400); biotin (80 mg); Saccharomyces cerevisiae (1.5 × 109); monensin (500 mg); fluorine (300 mg). 2 Dry matter (DM); 3 Crude protein (CP); 4 Acid detergent fiber (ADF); 5 Neutral detergent fiber (NDF); 6 Calcium (Ca); 7 Phosphorus (P); 8 Metabolizable energy (ME); 9 Net energy for lactation (NEL); 10 Selenium (Se).
Table 2. Average values ± standard error of colostrum brix index (%) and immunoglobulin G (IgG; g/L) of Holstein cows who were or were not submitted to supplementation with diphenyl diselenide at 42, 28, and 14 days prior to calving and distributed in groups: diphenyl diselenide (DDG), dimethyl sulfoxide (DMSOG), and NaCl (NACLG) (average ± standard error, n = 6/treatment).
Table 2. Average values ± standard error of colostrum brix index (%) and immunoglobulin G (IgG; g/L) of Holstein cows who were or were not submitted to supplementation with diphenyl diselenide at 42, 28, and 14 days prior to calving and distributed in groups: diphenyl diselenide (DDG), dimethyl sulfoxide (DMSOG), and NaCl (NACLG) (average ± standard error, n = 6/treatment).
ParametersGroupValues
Brix index
(%)		NACLG 124.87 ± 1.21
DMSOG 224.62 ± 0.80
DDG 325.50 ± 1.54
IgG 4
(g/L)		NACLG 1111.67 ± 11.18
DMSOG 2106.70 ± 12.83
DDG 3113.83 ± 12.29
Means followed by distinct capital letters refer to differences (p < 0.05) between groups (vertical; column). 1 NaCl group (NACLG); 2 Dimethyl sulfoxide group (DMSOG); 3 Diphenyl diselenide group (DDG); 4 Immunoglobulin G (IgG).
Table 3. Composition of the mineral and vitamin supplement provided to Holstein calves from birth (day 0) to 70 days of life, distributed into different experimental groups.
Table 3. Composition of the mineral and vitamin supplement provided to Holstein calves from birth (day 0) to 70 days of life, distributed into different experimental groups.
IngredientQuantities/kg *
Vitamin A (IU/kg)74,806
Vitamin D3 (IU/kg)21,210
Vitamin E (IU/kg)1090
Calcium (g/kg)175.2
Chlorine (g/kg)24.6
Crude protein (g/kg)119.5
Ethereal extract (g/kg)54.2
Lactose (g/kg)70.5
Sodium (g/kg)16.5
Biotin (mg/kg)25
Chromium (mg/kg)8.3
Cobalt (mg/kg)4.4
Cooper (mg/kg)354.8
Fluorine (mg/kg)295
Iodine (mg/kg)15
Magnesium (mg/kg)1500
Manganese (mg/kg)1068.2
Monensin (mg/kg)700
Phosphorus (mg/kg)8000
Potassium (mg/kg)2500
Selenium (mg/kg)6.5
Sulfur (mg/kg)300
Zinc (mg/kg)1022.1
Saccharomyces cerevisiae (CFU/kg)1.0 × 1011
* minimal vitamin and mineral levels per kg of product.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rodrigues, C.M.; Parmeggiani, E.B.; Leal, K.W.; Schneider, M.; Collet, S.G.; Cibin, F.W.S.; Gomes, V.; Blagitz, M.G.; Rocha, J.B.T.d.; Leal, M.L.d.R. Effect of Prepartum Maternal Supplementation with Diphenyl Diselenide on Biochemical, Immunological, and Oxidative Parameters of the Offspring. Animals 2024, 14, 10. https://doi.org/10.3390/ani14010010

AMA Style

Rodrigues CM, Parmeggiani EB, Leal KW, Schneider M, Collet SG, Cibin FWS, Gomes V, Blagitz MG, Rocha JBTd, Leal MLdR. Effect of Prepartum Maternal Supplementation with Diphenyl Diselenide on Biochemical, Immunological, and Oxidative Parameters of the Offspring. Animals. 2024; 14(1):10. https://doi.org/10.3390/ani14010010

Chicago/Turabian Style

Rodrigues, Cláudia Medeiros, Eliana Burtet Parmeggiani, Karoline Wagner Leal, Marla Schneider, Silvana Giacomini Collet, Francielli Weber Santos Cibin, Viviani Gomes, Maiara Garcia Blagitz, João Batista Teixeira da Rocha, and Marta Lizandra do Rêgo Leal. 2024. "Effect of Prepartum Maternal Supplementation with Diphenyl Diselenide on Biochemical, Immunological, and Oxidative Parameters of the Offspring" Animals 14, no. 1: 10. https://doi.org/10.3390/ani14010010

APA Style

Rodrigues, C. M., Parmeggiani, E. B., Leal, K. W., Schneider, M., Collet, S. G., Cibin, F. W. S., Gomes, V., Blagitz, M. G., Rocha, J. B. T. d., & Leal, M. L. d. R. (2024). Effect of Prepartum Maternal Supplementation with Diphenyl Diselenide on Biochemical, Immunological, and Oxidative Parameters of the Offspring. Animals, 14(1), 10. https://doi.org/10.3390/ani14010010

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop